Evidence map›Paper›PMID 25814787›Full record

ArticleMediators of inflammation2015

Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy.

Caroline Schmidt-Lucke, Felicitas Escher, Sophie Van Linthout, Uwe Kühl, Kapka Miteva, Jochen Ringe, Thomas Zobel, Heinz-Peter Schultheiss, Carsten Tschöpe

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Caroline Schmidt-LuckeDepartment of Cardiology, Charité-University Medicine Berlin, Campus Benjamin Franklin, 12200 Berlin, Germany ; Berlin-Brandenburg Center of Regenerative Therapies (BCRT), 13353 Berlin, Germany ; Medico-Academic Consultings (MEDIACC), 14193 Berlin, Germany.
Felicitas EscherDepartment of Cardiology, Charité-University Medicine Berlin, Campus Rudolf Virchow, 13353 Berlin, Germany ; German Center for Cardiovascular Research (DZHK), 10117 Berlin, Germany ; Institute of Cardiac Diagnostics and Therapy (IKDT), 12203 Berlin, Germany.
Sophie Van LinthoutDepartment of Cardiology, Charité-University Medicine Berlin, Campus Rudolf Virchow, 13353 Berlin, Germany ; German Center for Cardiovascular Research (DZHK), 10117 Berlin, Germany.
Uwe KühlDepartment of Cardiology, Charité-University Medicine Berlin, Campus Rudolf Virchow, 13353 Berlin, Germany ; Institute of Cardiac Diagnostics and Therapy (IKDT), 12203 Berlin, Germany.
Kapka MitevaBerlin-Brandenburg Center of Regenerative Therapies (BCRT), 13353 Berlin, Germany.
Jochen RingeBerlin-Brandenburg Center of Regenerative Therapies (BCRT), 13353 Berlin, Germany.ORCID 0000-0002-4246-8213
Thomas ZobelDepartment of Cardiology, Charité-University Medicine Berlin, Campus Benjamin Franklin, 12200 Berlin, Germany.ORCID 0000-0002-2520-6385
Heinz-Peter SchultheissInstitute of Cardiac Diagnostics and Therapy (IKDT), 12203 Berlin, Germany.
Carsten TschöpeBerlin-Brandenburg Center of Regenerative Therapies (BCRT), 13353 Berlin, Germany ; Department of Cardiology, Charité-University Medicine Berlin, Campus Rudolf Virchow, 13353 Berlin, Germany ; German Center for Cardiovascular Research (DZHK), 10117 Berlin, Germany.
Berlin-Brandenburger Centrum für Regenerative Therapien · DEGerman Centre for Cardiovascular Research · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECS Diagnostics · DEFranklin University · USMedico-Academic Consultings (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. Mesenchymal stromal cells (MSC) have immunomodulatory features. The aim of this study was to investigate the migration and homing potential of endogenous circulating MSC in virus negative inflammatory cardiomyopathy (CMi). Methods. In 29 patients with (n = 23) or without (n = 6) CMi undergoing endomyocardial biopsies (EMB), transcardiac gradients (TCGs) of circulating MSC were measured by flow cytometry from blood simultaneously sampled from aorta and coronary sinus. The presence of MSC in EMB, cardiac inflammation, and SDF-1α mRNA expression were detected via immunohistochemistry and real-time PCR. Results. MSC defined as CD45(-)CD34(-)CD11b(-)CD73(+)CD90(+) cells accounted for 0.010 [0.0025-0.048]%/peripheral mononuclear cell (PMNC) and as CD45(-)CD34(-)CD11b(-)CD73(+)CD105(+) cells for 0.019 [0.0026-0.067]%/PMNC, both with similar counts in patients with or without cardiac inflammation. There was a 29.9% (P < 0.01) transcardiac reduction of circulating MSC in patients with CMi, correlating with the extent of cardiac inflammation (P < 0.05, multivariate analysis). A strong correlation was found between the TCG of circulating MSC and numbers of MSC (CD45(-)CD34(-)CD90(+)CD105(+)) in EMB (r = -0.73, P < 0.005). SDF-1α was the strongest predictor for increased MSC in EMB (P < 0.005, multivariate analysis). Conclusions. Endogenous MSC continuously migrate to the heart in patients with CMi triggered by cardiac inflammation.

Indexed as

AdolescentAdultAgedBiopsyCardiomyopathiesCell MovementChemokine CCL2Chemokine CXCL12FemaleHumansInflammationMaleMesenchymal Stem CellsMiddle AgedMyocardiumCCL2 protein, humanChemokine CCL2Chemokine CXCL12CXCL12 protein, human

Identifiers

PMID25814787
PMCPMC4359807
OpenAlexW2034393732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.